Clinical trial
A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA…
NCT00195403 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195403 |
|---|---|
| Title | A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA |
| Official title | A Drug Use Investigation of Enbrel for Post-Marketing Surveillance |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Etanercept |
| Enrollment | 1,014 |
| Start date | May 1, 2004 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Aug 15, 2013 |
| Countries | South Korea |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: